Search results
Sleep and Social Media Impact Youth Brain Development
Medscape· 10 hours agoA study of teens revealed distinct interactions between sleep duration, social media use, and brain...
1 Growth Stock Down 88% to Buy Right Now
Motley Fool via Yahoo Finance· 3 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
ZOMBIE FORECLOSURES SHRINK TO EVEN SMALLER PORTION OF U.S. HOUSING STOCK IN SECOND QUARTER
Benzinga· 5 days agoThe report analyzes publicly recorded real estate data collected by ATTOM — including foreclosure status, equity and owner-occupancy status — matched against monthly updated
Vaccines Fast Facts – KION546
KION 46 Salinas· 6 days agoThe Centers for Disease Control and Prevention (CDC) provides vaccine recommendations by age, as well as by disease. For more than 100 years, there has...
Realty Income: Buy, Sell, or Hold?
Motley Fool via Yahoo Finance· 5 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
The Maternal-Mortality Crisis That Didn’t Happen
The Atlantic· 5 days agoIn 2019, the United States recorded twice as many maternal deaths as in 1999. The notion that the U.S. has fallen behind other highly developed nations...
Theralase(R) Technology Effective in Virus Inactivation
Morningstar· 4 hours agoTORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
US authorities arrest administrator behind 'likely world's largest botnet ever'
TweakTown· 3 days agoUS authorities have arrested the alleged administrator behind 'likely the world's largest botnet...
Theralase(R) Technology Effective in Virus Inactivation
The Joplin Globe· 3 hours agoTORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
Morningstar· 4 hours agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a slow bolus intravenous infusion, resulted in a relatively flat plateau of blood ...